The therapies are poised to revolutionize the cancer care landscape, but it will require collaboration across the industry, ...

Minneapolis, MN, Feb. 11, 2025 (GLOBE NEWSWIRE) -- United Theranostics ... N.J. We expect our rate of clinic growth to accelerate throughout 2025 and 2026, further establishing our nationwide ...

Financial Health for Radiopharm Theranostics is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.

Siemens Healthineers is positioning itself to benefit from the growing demand for theranostics by partnering with healthcare providers to provide more than equipment. Theranostics, which combines ...

Radiopharm Theranostics Limited engages in the research ... of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other ...